Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

AarogyaAI is a software-as-a-service platform that utilizes artificial intelligence to identify drug-resistant tuberculosis (DR-TB) within hours. Our goal is to provide rapid and precise diagnoses of DR-TB, ensuring that patients receive the most effective drug combinations for their treatment without delay. Tuberculosis is responsible for more fatalities annually than AIDS, largely because the 19 available anti-TB medications do not work for all patients, leading to uncertainty among doctors regarding the appropriate treatment options. Consequently, even though tuberculosis is treatable, a delayed diagnosis of drug-resistant forms can result in patients remaining on ineffective medications for as long as seven years. By diagnosing drug-resistant tuberculosis swiftly, we enable prompt and appropriate treatment prescriptions. Patients upload a DNA sequence to our platform, and our advanced machine learning algorithm processes this data to generate a detailed report on drug susceptibility status, allowing healthcare providers to make informed decisions about treatment. This innovative approach not only enhances patient outcomes but also aims to reduce the overall burden of tuberculosis on healthcare systems.

Description

The red dot® algorithm we utilize swiftly identifies and highlights irregularities in images with remarkable precision. This advanced AI system has been crafted using a dataset of over 30,000 images, all meticulously evaluated by certified Consultant Radiologists from the UK. With continuous refinement by these highly skilled professionals, our red dot® algorithm maintains an impressive accuracy rate exceeding 90%. The ability to detect abnormalities in mere seconds ensures that patients receive diagnoses even before they leave the hospital. Furthermore, our AI technology enhances current reporting processes and seamlessly integrates with existing Radiology Information Systems (RIS) or Picture Archiving and Communication Systems (PACS), regardless of the vendor. Behold.ai has proven to be a highly cost-efficient solution, effectively alleviating reporting backlogs and capacity challenges while being up to 50% less expensive than outsourced reporting options. Recognized globally, behold.ai has earned a spot among the Top 100 Digital Health companies and is one of only five selected for AI diagnosis worldwide, showcasing its commitment to innovation in healthcare. This recognition underscores the transformative impact our technology is having on medical diagnostics and patient care.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

AarogyaAI

Country

India

Website

aarogya.ai/

Vendor Details

Company Name

Behold.ai

Country

United Kingdom

Website

behold.ai/

Product Features

Product Features

Medical Imaging

Automated Routing
Comparison View
Compliance Management
Data Import / Export
Diagnostic Reporting
Image Analytics
Treatment Planning
Workflow Management

Alternatives

Alternatives

AIDDISON Reviews

AIDDISON

Merck KGaA
qCT Reviews

qCT

Qure.ai